Search

everythinglearnresearchcommunity

for

Search:↓

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

PRP shows promise for treating hair loss, but more research is needed.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

The black orchid Brasiliorchis schunkeana produces chemicals that attract certain insects and have potential antimicrobial properties.

Photobiomodulation can improve hair density and thickness, but it's costly and needs more research.

Australian dermatologists often prescribe spironolactone and minoxidil for female hair loss.

Androgenetic alopecia is a genetic hair loss condition, more severe in men, and can also be caused by hormonal imbalances in women.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Low-level light therapy, possibly combined with other treatments, may become a leading hair loss treatment, while hirsutism often worsens with age and lacks preventive options.

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

Hormones, especially androgens, affect hair growth and can cause hair loss or excess hair in both men and women.

Two cosmetic lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.

Platelet-rich plasma treatment significantly improved hair density and regrowth in both men and women suffering from pattern hair loss, with even better results when combined with certain medications.

Finasteride helps female-pattern hair loss.

Finasteride helps female-pattern hair loss.

Women using 5% minoxidil for hair loss were mostly satisfied and had improved quality of life, despite some impact on social life and hairstyle choices.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

Men with severe hair loss may have poorer sperm quality.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.

Severe hair loss is linked to worse COVID-19 outcomes, especially in younger men.

Androgenetic alopecia is common hair loss due to genetics and hormones, manageable with early treatment.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Hair disorders can be genetic or acquired, affecting hair growth and loss differently.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Topical minoxidil and oral finasteride can help regrow hair in androgenetic alopecia.